These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28186077)

  • 1. Designing a Surveillance System in Canada to Detect Adverse Interactions Between Traditional Chinese Medicine and Western Medicine: Issues and Considerations.
    Zhang J; Ho K
    Stud Health Technol Inform; 2017; 234():412-417. PubMed ID: 28186077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China.
    Williamson EM; Lorenc A; Booker A; Robinson N
    J Ethnopharmacol; 2013 Sep; 149(2):453-62. PubMed ID: 23832055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.
    Cheng CW; Bian ZX; Li YP; Moher D; Wu TX; Dagenais S; Li J; Li TQ
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):881-6. PubMed ID: 18782527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status and development of monitoring on adverse reaction of traditional Chinese medicine in China].
    Zhang L; Yang XH; Cao LY; Ji S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):581-4. PubMed ID: 16089130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese medicine adverse reactions' literature statistical analysis in recent five years].
    Xiang F; Zhang X
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2755-8. PubMed ID: 22242443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview on adverse drug reactions to traditional Chinese medicines.
    Chan K; Zhang H; Lin ZX
    Br J Clin Pharmacol; 2015 Oct; 80(4):834-43. PubMed ID: 25619530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese medicine: herb-drug interactions with aspirin.
    Lim JW; Chee SX; Wong WJ; He QL; Lau TC
    Singapore Med J; 2018 May; 59(5):230-239. PubMed ID: 29796686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological risks of Chinese herbs.
    Shaw D
    Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China.
    Li H; Deng J; Deng L; Ren X; Xia J
    Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):1002-1013. PubMed ID: 31131950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally derived anti-inflammatory compounds from Chinese medicinal plants.
    Wang Q; Kuang H; Su Y; Sun Y; Feng J; Guo R; Chan K
    J Ethnopharmacol; 2013 Mar; 146(1):9-39. PubMed ID: 23274744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between traditional Chinese medicine and western drugs in Taiwan: A population-based study.
    Chen KC; Lu R; Iqbal U; Hsu KC; Chen BL; Nguyen PA; Yang HC; Huang CW; Li YC; Jian WS; Tsai SH
    Comput Methods Programs Biomed; 2015 Dec; 122(3):462-70. PubMed ID: 26470816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do government regulations influence the ability to practice Chinese herbal medicine in western countries.
    Fleischer T; Su YC; Lin SJ
    J Ethnopharmacol; 2017 Jan; 196():104-109. PubMed ID: 27915077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnosis and Management of Allergic Reactions Caused by Chinese Materia Medica.
    Shi Y; Tang R; Luo F; Li H; Pan Z; Xu G; Yang Y; Zhao Z; Liang A; Wei JF; Piao Y; Chang C; Sun JL; Platts-Mills TAE
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):103-122. PubMed ID: 33606192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A U.S. perspective on the adverse reactions from traditional Chinese medicines.
    Ko RJ
    J Chin Med Assoc; 2004 Mar; 67(3):109-16. PubMed ID: 15181962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring].
    Wang D; Du XX
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2686-8. PubMed ID: 23285908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
    Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
    J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
    Jiang JJ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protocol of intensive hospital monitoring with long follow up and large sample: Diemailing Kudiezi injection as example].
    Liao X; Xie YM; Wang GQ
    Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(24):4494-4499. PubMed ID: 28936829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.